PIL Logistics has launched a new logo and refreshed brand identity which signals a closer collaboration with its parent ...

“Some may call it an SOB and the vexillogical community (flag experts) may hate it, but people overwhelmingly prefer our ...

In a report released today, Steven Sassine from Morgans maintained a Buy rating on Camplify Holdings Ltd. (CHL – Research Report), with a price target of A$1.05. The company’s shares opened ...

Heading into the 2025 season, the Louisville Bats will have a new logo that draws on the history of the franchise and the legacy of where they play - Louisville, Kentucky. The Bats are the Triple ...

TL;DR: If you're looking for a powerful productivity suite without recurring subscription fees, Microsoft Office 2021 is available for just $54 for a limited time – an incredible deal and one of ...

After a passenger unexpectedly died on a flight from Australia, their body remained seated next to a couple for hours. The incident occurred during the 15-hour flight from Melbourne to Doha.

The Obidient Movement has unveiled a new logo ahead of Nigeria’s 2027 general elections, reinforcing its commitment to accountability, equity, and good governance. In a statement on Tuesday ...

Originally created by software engineer Josh Wardle and released to the public in 2021, the puzzle was acquired by The New York Times in 2022 after rising to huge popularity. Players can pick any ...

Ubiquiti continues to be a leader in the enterprise networking industry with three new 10-gigabit UniFi Cloud Gateways designed to future-proof networks. In the last five years, the company has ...

However, the sources didn’t provide a new release date for DeepSeek-R2, which has yet to be announced. We don’t know much about DeepSeek’s next AI model yet, but the Chinese company wants R2 ...

Now, a popular Apple insider has given some insight into a new duo of iPhones set to arrive next year. The report comes from Mark Gurman of Bloomberg – a man widely regarded as the top inside ...

The review highlights next-generation therapies that specifically target PIK3CA mutations with improved selectivity and reduced toxicity. Several promising inhibitors, including RLY-2608 ...